igf-1 lr3 risks hypoglycemia organ growth 40 YEARS OF IGF1: Insulin-like factors: actions on the skeleton in: Journal of Molecular Endocrinology Volume 61 Issue 1 (2018) IGF-1 LR3 peptide: complete guide
Description
2021 Jun 15;2:690686
Not all ER-positive BC patients are responsive to endocrine therapy ( de novo resistance)
They are particularly valuable in studying protein-protein interactions through techniques such as pull-down assays
Rolland et al
Chintakuntlawar, Jessica L
Exp Biol Med (Maywood) 228(8):891897 Koshinaka K, Toshinai K, Mohammad A, Noma K, Oshikawa M, Ueno H, Yamaguchi H, Nakazato M (2011) Therapeutic potential of ghrelin treatment for unloading-induced muscle atrophy in mice
